Pharmacological treatments of COVID-19

The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19), which was reported for the first time in December 2019, was named by the World Health Organization (WHO) as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV2), because of the very similar genome and also...

詳細記述

保存先:
書誌詳細
出版年:Pharmacol Rep
主要な著者: Sahebnasagh, Adeleh, Avan, Razieh, Saghafi, Fatemeh, Mojtahedzadeh, Mojataba, Sadremomtaz, Afsaneh, Arasteh, Omid, Tanzifi, Asal, Faramarzi, Fatemeh, Negarandeh, Reza, Safdari, Mohammadreza, Khataminia, Masoud, Rezai Ghaleno, Hassan, Habtemariam, Solomon, Khoshi, Amirhosein
フォーマット: Artigo
言語:Inglês
出版事項: Springer International Publishing 2020
主題:
Review
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7439639/
https://ncbi.nlm.nih.gov/pubmed/32816200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s43440-020-00152-9
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料